JONATHAN D. ROOT - 03 Mar 2021 Form 4 Insider Report for Silverback Therapeutics, Inc. (SPRY)

Role
Director
Signature
Dale Holladay, Attorney in Fact for the Reporting Person
Issuer symbol
SPRY
Transactions as of
03 Mar 2021
Transactions value $
$36,048
Form type
4
Filing time
18 Mar 2022, 17:14:40 UTC
Previous filing
18 Mar 2022
Next filing
17 May 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SPRY Common Stock Purchase $18.2K +350 $52.07* 350 03 Mar 2021 Directly owned by Spouse F1
transaction SPRY Common Stock Purchase $17.8K +2.01K +575.43% $8.85 2.36K 15 Nov 2021 Directly owned by Spouse F1
holding SPRY Common Stock 2.07M 03 Mar 2021 Directly owned by USVP X F2
holding SPRY Common Stock 105K 03 Mar 2021 Directly owned by AFF X F2
holding SPRY Common Stock 95.2K 03 Mar 2021 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares are being reported following the discovery that shares of the issuer were purchased in discretionary IRA accounts held by the spouse of the reporting person. The reporting person is not an owner of such IRA accounts. The total in Column 5 of Table I does not reflect previously reported transactions that occurred after 3/3/2021.
F2 Presidio Management Group XII, L.L.C. (PMG XII), the general partner of U.S. Venture Partners XII, L.P. and U.S. Venture Partners XII-A, L.P. (together, USVP XII), has sole voting and dispositive power with respect to the shares held by USVP XII. The reporting person is a managing member of PMG XII, and shares voting and dispositive power with respect to the shares held by USVP XII. The reporting person disclaims beneficial ownership of such holdings, except to the extent of his pecuniary interest in the shares.